Federal contract award
W911SR23F0049
PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W6QK ACC-APG |
| NAICS | 541712 |
| PSC | AC11 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; BASIC RESEARCH |
| Parent award / vehicle | GS00Q14OADU402 |
| Set-aside | Not reported |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $22.6M |
| Current contract value | $49.5M |
| Potential contract value / ceiling | $49.5M |
| Start date | Feb 17, 2023 |
| Current end date | Feb 16, 2028 |
| Potential end date | Feb 16, 2028 |
| Latest award activity | Jan 30, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 29 of 29 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 10, 2026 | P00028 | $-321.0K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002, CLIN 0003, AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Jan 30, 2026 | P00027 | $1.1M | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002, CLIN 0003, AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Jan 21, 2026 | P00026 | $-252.1K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002, CLIN 0003, AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Dec 16, 2025 | P00025 | $676.9K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002, CLIN 0003, AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Sep 26, 2025 | P00024 | $957.5K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002 AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Sep 18, 2025 | P00023 | $333.9K | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002 AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Aug 15, 2025 | P00022 | $2.3M | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002 AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Jul 30, 2025 | P00021 | $3.3M | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING TO CLIN 0002 AND CLIN 0006 UNDER DELIVERY ORDER W911SR-23-F-0049. SEE SUMMARY OF CHANGES. |
| Apr 28, 2025 | P00020 | $2.9M | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Mar 14, 2025 | P00019 | $20.0K | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Feb 4, 2025 | P00018 | $1.5M | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Dec 11, 2024 | P00017 | $631.6K | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Nov 6, 2024 | P00016 | $754.4K | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Sep 3, 2024 | P00015 | $1.1M | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Jun 6, 2024 | P00014 | $0 | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Jun 4, 2024 | P00013 | $0 | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| May 23, 2024 | P00012 | $1.8M | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Apr 5, 2024 | P00011 | $236.8K | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Feb 27, 2024 | P00010 | $946.1K | TO DESIGN AND CONDUCT NONCLINICAL RESEARCH STUDIES, DEVELOP SUPPORTING ASSAYS AND REAGENTS, INTERPRET AND REPORT STUDY RESULTS AND ANALYSIS, AND EVALUATE ADVANCED DEVELOPMENT CANDIDATES FOR REPURPOSED MEDICAL PRODUCTS AND VACCINE DEVELOPMENT. |
| Jan 11, 2024 | P00009 | $201.2K | NON-CLNICAL STUDIES |
| Jan 9, 2024 | P00008 | $517.1K | NON-CLNICAL STUDIES |
| Nov 16, 2023 | P00007 | $262.9K | COUNTERING EMERGING THREATS RAPID ACQUISITION AND INVESTIGATION OF DRUGS FOR REPURPOSING DEVELOPMENT SUPPORT STUDIES. |
| Aug 29, 2023 | P00006 | $282.2K | NON-CLNICAL STUDIES |
| Aug 15, 2023 | P00005 | $460.9K | NON-CLNICAL STUDIES |
| Aug 7, 2023 | P00004 | $554.1K | NON-CLNICAL STUDIES |
| Jul 20, 2023 | P00003 | $188.7K | NON-CLNICAL STUDIES |
| Jun 7, 2023 | P00002 | $61.9K | NON-CLINICAL STUDIES |
| May 24, 2023 | P00001 | $376.4K | NON-CLNICAL STUDIES |
| Feb 17, 2023 | 0 | $1.5M | PERFORMANCE OF STUDIES IN SUPPORT OF THE CET-RAIDIR PROGRAM. |
Estimated positioning window
Feb 16, 2027 – Aug 16, 2027
Recompete signal: . Rule-based research score; positioning dates are estimates.
50/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 50/100. Available recorded signals: 45 points.
- Contract end 2028-02-16 (472 days from calculation)
- +25 points
- 1 historical awards in this buyer and category group
- +0 points
- 29 recorded award transactions
- +10 points
- Latest award action: 2026-01-30
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +0 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-11-01 10:17:53.997580+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Nov 1, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.